慢性肾脏病微炎症状态的诊断与治疗

被引:65
作者
梁莹
王妍春
机构
[1] 广州军区广州总医院肾脏内科
关键词
D O I
暂无
中图分类号
R692 [肾疾病];
学科分类号
100221 [泌尿外科学];
摘要
<正>微炎症状态(micro inflammatory state)是指非病原微生物感染引起的一种慢性持续性炎症反应,表现为全身循环中炎性蛋白、炎性因子水平轻度增高,具有持续性及相对隐匿性,其本质是免疫性炎症[1]。国内多数学者认为,这种微炎症状态并非由外源性或体内机会性病原微生物感染所引起,亦不等同于全身炎症反应综合征(systemic inflammatory
引用
收藏
页码:1186 / 1188
页数:3
相关论文
共 21 条
[1]
Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis [J].
Yang, Shi-Kun ;
Xiao, Li ;
Xu, Bo ;
Xu, Xiao-Xuan ;
Liu, Fu-You ;
Sun, Lin .
RENAL FAILURE, 2014, 36 (05) :722-731
[2]
Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: A population-based study (CoLaus Study).[J].Julien Vaucher;Pedro Marques-Vidal;Gérard Waeber;Peter Vollenweider.Cytokine.2014, 2
[3]
Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.[J].Ryo Kodera;Kenichi Shikata;Tetsuharu Takatsuka;Kaori Oda;Satoshi Miyamoto;Nobuo Kajitani;Daisho Hirota;Tetsuichiro Ono;Hitomi Kataoka Usui;Hirofumi Makino.Biochemical and Biophysical Research Communications.2013,
[4]
Anti-Inflammatory Profile of Paricalcitol in Hemodialysis Patients: A Prospective, Open-Label, Pilot Study [J].
Navarro-Gonzalez, Juan F. ;
Donate-Correa, Javier ;
Mendez, Maria L. ;
Muros de Fuentes, Mercedes ;
Garcia-Perez, Javier ;
Mora-Fernandez, Carmen .
JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (04) :421-426
[5]
Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy.[J].Akihiko Nakamura;Kenichi Shikata;Tatsuaki Nakatou;Takuya Kitamura;Nobuo Kajitani;Daisuke Ogawa;Hirofumi Makino.J Diabetes Invest.2012, 2
[6]
The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells [J].
Shiraki, Aya ;
Oyama, Jun-ichi ;
Komoda, Hiroshi ;
Asaka, Machiko ;
Komatsu, Aiko ;
Sakuma, Masashi ;
Kodama, Kazuhisa ;
Sakamoto, Yoshiko ;
Kotooka, Norihiko ;
Hirase, Tetsuaki ;
Node, Koichi .
ATHEROSCLEROSIS, 2012, 221 (02) :375-382
[7]
Cholecystokinin Plays a Novel Protective Role in Diabetic Kidney Through Anti-inflammatory Actions on Macrophage Anti-inflammatory Effect of Cholecystokinin [J].
Miyamoto, Satoshi ;
Shikata, Kenichi ;
Miyasaka, Kyoko ;
Okada, Shinichi ;
Sasaki, Motofumi ;
Kodera, Ryo ;
Hirota, Daisho ;
Kajitani, Nobuo ;
Takatsuka, Tetsuharu ;
Kataoka, Hitomi Usui ;
Nishishita, Shingo ;
Sato, Chikage ;
Funakoshi, Akihiro ;
Nishimori, Hisakazu ;
Uchida, Haruhito Adam ;
Ogawa, Daisuke ;
Makino, Hirofumi .
DIABETES, 2012, 61 (04) :897-907
[8]
Effects of L-carnitine Supplement on Serum Amyloid A and Vascular Inflammation Markers in Hemodialysis Patients: A Randomized Controlled Trial [J].
Tabibi, Hadi ;
Hakeshzadeh, Fariba ;
Hedayati, Mehdi ;
Malakoutian, Tahereh .
JOURNAL OF RENAL NUTRITION, 2011, 21 (06) :485-491
[9]
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes [J].
Kodera, R. ;
Shikata, K. ;
Kataoka, H. U. ;
Takatsuka, T. ;
Miyamoto, S. ;
Sasaki, M. ;
Kajitani, N. ;
Nishishita, S. ;
Sarai, K. ;
Hirota, D. ;
Sato, C. ;
Ogawa, D. ;
Makino, H. .
DIABETOLOGIA, 2011, 54 (04) :965-978
[10]
Comparative Effects of 10-mg Versus 80-mg Atorvastatin on High-Sensitivity C-Reactive Protein in Patients with Stable Coronary Artery Disease: Results of the CAP (Comparative Atorvastatin Pleiotropic Effects) Study [J].
Bonnet, Jacques ;
McPherson, R. ;
Tedgui, A. ;
Simoneau, D. ;
Nozza, A. ;
Martineau, P. ;
Davignon, Jean .
CLINICAL THERAPEUTICS, 2008, 30 (12) :2298-2313